Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia

BACKGROUND: Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is often severe and hard to treat compared to CL caused by other species elsewhere. Miltefosine is the only oral anti-leishmanial drug, with a favorable side-effect profile compared to routinely available sodium s...

Descripción completa

Detalles Bibliográficos
Autores principales: van Henten, Saskia, Tesfaye, Annisa Befekadu, Abdela, Seid Getahun, Tilahun, Feleke, Fikre, Helina, Buyze, Jozefien, Kassa, Mekibib, Cnops, Lieselotte, Pareyn, Myrthe, Mohammed, Rezika, Vogt, Florian, Diro, Ermias, van Griensven, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191986/
https://www.ncbi.nlm.nih.gov/pubmed/34048461
http://dx.doi.org/10.1371/journal.pntd.0009460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191986/
https://www.ncbi.nlm.nih.gov/pubmed/34048461
http://dx.doi.org/10.1371/journal.pntd.0009460

Ejemplares similares